Kathrin Philipp‐Abbrederis

Author

Technical University of Munich

Also Known As

K. Philipp-Abbrederis, Kathrin Philipp-Abbrederis, Kathrin Philipp‐Abbrederis

Publications

850

Citations

H-Index

Concepts

All Affiliations

Technical University of Munich Heidelberg University German Cancer Research Center Innsbruck Medical University Comprehensive Cancer Center Mainfranken

About

Kathrin Philipp‐Abbrederis is an author at Technical University of Munich specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	227
2	Immunology	2	2	216
3	Health Sciences	1	1	11
4	Cell Biology	1	1	206
5	Pathology	1	1	11

Kathrin Philipp‐Abbrederis

Publications

838

Citations

H-Index

Page 1

	Year	Citations
<i>In vivo</i> molecular imaging of chemokine receptor <scp>CXCR</scp> 4 expression in patients with advanced multiple myeloma Kathrin Philipp‐Abbrederis, Ken Herrmann, Stefan Knop, EMBO Molecular Medicine Hematological MalignancyAdvanced Multiple MyelomaMedicineMalignant Blood DisorderImmunology	2015	206
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging Hans Wester, Ulrich Keller, Margret Schottelius, Theranostics	2015	194
First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers Tibor Vág, Peter Herhaus, Matthias Eiber, Journal of Nuclear Medicine	2016	144
Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Journal of Clinical Oncology	2022	120
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia Peter Herhaus, Stefan Habringer, Kathrin Philipp‐Abbrederis, Haematologica	2016	65
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional study Jakob M. Riedl, Florian Posch, Gerald W. Prager, Therapeutic Advances in Medical Oncology	2020	62
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study Gerald W. Prager, Leopold Oehler, Armin Gerger, European Journal of Cancer	2020	26
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma. Zhoulei Li, Ken Herrmann, Sabine Pirsig, PubMed Oncologic ImagingSorafenib TreatmentPathologyGliomaTumor Biology	2013	11
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies Verena Petzer, Normann Steiner, Olga Angelova-Unterberger, HemaSphere ImmunodeficienciesImmunologyCovid-19 VaccinesImmunodominanceCovid-19 Epidemiology	2022	10

Page 1